Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin M McCartney

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
World Journal of Gastroenterology|March 19, 2010
Impact of alcohol on hepatitis C virus replication and interferon signalingErin M McCartney, Michael R Beard
Antiviral Research|January 15, 2008
A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylationKarla J Helbig, Evelyn Yip, Erin M McCartney, et al.
Hepatology (Baltimore, Md.)|May 25, 2013
Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virusErin M McCartney, Karla J Helbig, Sumudu K Narayana, et al.
The Journal of Infectious Diseases|October 30, 2008
Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferonErin M McCartney, Ljiljana Semendric, Karla J Helbig, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 15, 2015
Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of InterferonEdmund Tse, Karla J Helbig, Kylie Van der Hoek, et al.
The Journal of Biological Chemistry|September 11, 2015
The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus EntrySumudu K Narayana, Karla J Helbig, Erin M McCartney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2024
Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities-the PROMPt StudyErin M McCartney, Lucy Ralton, Joshua Dawe, et al.
Journal of Medical Virology|November 27, 2023
Assessment of hepatitis B virus infection and interhost cellular responses using intrahepatic cholangiocyte organoidsChuan K Lim, Ornella Romeo, Bang M Tran, et al.
Viruses|January 8, 2025
Findings from a Project Which Established Hepatitis C Point-of-Care Testing and Linkage to Care at a Homelessness Service in Adelaide, Australia, 2021-2022Erin M McCartney, Joshua Dawe, Lucy Ralton, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5AKarla J Helbig, Nicholas S Eyre, Evelyn Yip, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
World Journal of Gastroenterology|March 19, 2010
Impact of alcohol on hepatitis C virus replication and interferon signalingErin M McCartney, Michael R Beard
Antiviral Research|January 15, 2008
A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylationKarla J Helbig, Evelyn Yip, Erin M McCartney, et al.
Hepatology (Baltimore, Md.)|May 25, 2013
Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virusErin M McCartney, Karla J Helbig, Sumudu K Narayana, et al.
The Journal of Infectious Diseases|October 30, 2008
Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferonErin M McCartney, Ljiljana Semendric, Karla J Helbig, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 15, 2015
Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of InterferonEdmund Tse, Karla J Helbig, Kylie Van der Hoek, et al.
The Journal of Biological Chemistry|September 11, 2015
The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus EntrySumudu K Narayana, Karla J Helbig, Erin M McCartney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2024
Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities-the PROMPt StudyErin M McCartney, Lucy Ralton, Joshua Dawe, et al.
Journal of Medical Virology|November 27, 2023
Assessment of hepatitis B virus infection and interhost cellular responses using intrahepatic cholangiocyte organoidsChuan K Lim, Ornella Romeo, Bang M Tran, et al.
Viruses|January 8, 2025
Findings from a Project Which Established Hepatitis C Point-of-Care Testing and Linkage to Care at a Homelessness Service in Adelaide, Australia, 2021-2022Erin M McCartney, Joshua Dawe, Lucy Ralton, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5AKarla J Helbig, Nicholas S Eyre, Evelyn Yip, et al.
Pageof 2